Welcome to the website and services provided by NCV Media, LLC,
(“New Cannabis Ventures”), which can be found at www.newcannabisventures.com, (the “Site”).

New Cannabis Ventures connects the cannabis industry through curated content on only the most promising cannabis companies and the most influential investors, allowing its visitors to save time as they stay on top of the latest trends in this dynamic industry. Curated content that gets published ranges from company specific to industry wide news, as well as information, opinion, analysis and commentary.

The Site and any information therein are provided without warranty of any kind, including the implied warranties of merchantability, fitness for use of a particular purpose, accuracy, or non-infringement. New Cannabis Ventures does not guarantee that the Site will operate in an uninterrupted or error-free manner or is free of viruses or other harmful components. Use of information obtained from or through the Site is at your own risk. The Site is not liable for any loss or damages including, but not limited to, claims for defamation, errors, loss of data, loss of money, or interruption in availability of data arising out of the use or inability to use the Site or any links; to your placement of content on the Site; or to your reliance upon information obtained from or through the Site or through links contained on the Site.

This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. New Cannabis Ventures does not condone the use of cannabis except where permissible by state law. The Site does not possess, distribute, or sell cannabis products.

Commerce Policy
New Cannabis Ventures receives affiliate payments through various partners which includes the Cannabis Capital Conference, by Benzinga and the newsletter subscription service, 420 Investor.

Responsible awareness and public disclosure
New Cannabis Ventures is proud to offer fact-based, data-driven “Investor Dashboards” for publicly-traded advertising clients. The information displayed on each Investor Dashboard is often based on regulatory filings from SEC, SEDAR or a common regularly authority, official company press releases or publicly available company brochures. Advertising the Investor Dashboards, maintaining its data and the complimentary ad banners that come with it is the solution New Cannabis Ventures provides. Clients cannot buy the ability to publish favorable articles on the platform. The goal of the Investor Dashboard is to ensure the reader has the most up to date and factual information that is publicly available. All data and info is provided “as is” and solely for informational purposes, not for trading or investment advice. New Cannabis Ventures does not accept any form of compensation from publicly-traded companies unless they are disclosed below. Pricing for the Investor Dashboard product is made available on the New Cannabis Ventures advertising page.

NCV Media provides Investor Dashboards to the following publicly-traded companies
48North – Start date: 01/07/19, Aurora Cannabis – Start date: 10/1/16, Australis Capital – 10/30/18-04/29/19, Canopy Growth Corporation – Start date: 10/1/16, Canopy Rivers – 09/18/18-02/04/19, CB2 Insights – 03/06/19 (as a public company)-6/14/19, Charlotte’s Web – Start date: 09/06/18, Cresco Labs – Start date: 12/03/18 (as a public company), DionyMed Brands – Start date: 07/01/19, Emblem Corp. – 12/12/16 (as a public company)-02/28/19 (following agreement to merge with Aleafia Health), Emerald Health – 01/16/17-03/31/17, Fire and Flower – Start date: 06-26/19, GABY Inc – Start date: 8/14/19, Green Growth Brands – Start date: 11/13/18 (as a public company), GrowGeneration – 01/01/17-03/31/18, Harvest One Cannabis – Start date: 04/01/17, High Tide – 02/01/19-05/09/19, Hiku Brands (formerly DOJA Cannabis) – 7/25/17-7/31/18 (following agreement to merge with Canopy Growth), iAnthus Capital Holdings – Start date: 04/20/17, INDIVA – Start date: 07/24/18, Khiron Life Sciences – 05/23/18-08/22/18, KushCo Holdings (Kush Bottles) – Start date: 02/15/17, Liberty Health Sciences – Start date: 08/01/17, Medicine Man Technologies – Start date: 09/25/18, MediPharm Labs – Start date: 10/01/18, MJardin Group – 11/15/18-05/31/19 (as a public company), MPX Bioceutical Corporation (formerly The Canadian Bioceutical Corporation) – 06/15/17-01/31-19 (following acquisition by iAnthus Capital), MPX International – Start date 05/30/19, OrganiGram – 01/01/17-03/31/17 and since 09/12/18, Plus Products – Start date: 10/29/18 (as public company), RavenQuest BioMed – 11/28/17-08/31/18, Solis Tek –  04/16/17-10/31/17, Supreme Cannabis – Start date: 04/14/17, TerrAscend – Start date: 09/20/17, The Green Organic Dutchman -11/25/16-10/10/18, Therapix Biosciences –  03/22/17-07/26/17, TILT Holdings – Start date: 06/20/19, Vireo Health – Start date: 04/30/19, Vivo Cannabis (Formerly ABcann) – Start date: 04/24/17 (as a public company), Wayland Group Corp (formerly Maricann) – 04/22/17-04/30/19. We also provided the following companies with advertising services by including them on our Cannabis Careers page: Organigram – 05/30/18-08/29/18.

Publicly-traded client criteria
Please note as well, being a client of New Cannabis Ventures is not a recommendation of the company. In determining which public companies are eligible to be a client of New Cannabis Ventures, they must meet a minimum standard. Meeting these criteria is not a guarantee that New Cannabis Ventures will accept a company as a client. Note that there are slightly different standards for companies who have a license issued by federal or state governments. The criteria can be found at the bottom of this page.

Ancillary Company Criteria


  • $1 minimum stock price for annual sales <$5mm
  • $0.10 minimum stock price for annual sales >$5mm
  • No history of stock promotion
  • No toxic debt
  • Current in filings

Licensed Company Criteria


  • A license issued by federal or state government
  • A demonstrated capacity to raise capital
  • No history of stock promotion
  • No toxic debt
  • Current in filings